Tag: multiple sclerosis

May 7, 2019

TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis

TG Therapeutics (NASDAQ:TGTX) has announced presentation of long-term follow-up data of its Phase 2 open label extension trial of ubiltuximab...
February 28, 2019

An Investor’s Guide to Multiple Sclerosis

March was dubbed Multiple Scleorsis Awareness Month in 2015 by New Jersey Governor Chris Christie. Here's what investors should know.
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
April 11, 2018

Helius Medical Begins Listing on the NASDAQ

A company getting approval to list to the NASDAQ means a more international reach for Canadian companies listing on the...
April 9, 2018

CBD​ ​is​ ​Improving​ ​Health​ ​and​ ​Driving​ ​the​ ​Cannabis​ ​Industry

CBD​ ​is​ ​improving​ ​health​ ​and​ driving​ ​the​ ​cannabis​ ​industry. Know more about its health benefits and opportunities for CBD-based companies.
March 14, 2018

Biogen Announces Voluntary Drug Withdrawal and Pfizer Drug Acquisition Weeks Apart, Share Price Remains Steady

March has been a busy month for Biogen with its voluntary withdrawal of Zinbryta and its acquisition of Pfizer's PF-04958242.
March 1, 2018

Biocure appoints Lichtenwald CFO, director

Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the"Company" or "Biocure") is pleased to announce that effective of today's...